US FDA grants EUA for Novavax COVID-19 vaccine, adjuvanted for adolescents aged 12 through 17 years Read more
Novavax submits final data to US FDA as prerequisite to EUA application request for COVID-19 vaccine Read more
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study Read more